Kerry Group, a global taste and nutrition company, completed the acquisition of a 92% stake in c-LEcta, a biotechnology innovation company, specialising in precision fermentation, optimised bio-processing, and bio-transformation, for €137m. "We are very happy to join Kerry group and their global presence in the food and pharmaceutical sectors gives us access to additional markets. At the same time, their expertise in ingredient technologies and applications is a perfect fit as we continue to drive our growth potential in the future. We will continue to collaborate with our existing industry partners and will of course continue to produce and distribute our products for our valued customers,” Marc Struhalla, c-LEcta Founder and CEO.